Variant report

Variant	nsv1022798
Chromosome Location	chr9:1003739-1033354
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:1009225-1009309	K562	blood:	n/a	n/a
2	ATF1	chr9:1013083-1013384	K562	blood:	n/a	n/a
3	ATF3	chr9:1018242-1018408	K562	blood:	n/a	n/a
4	ATF3	chr9:1018219-1018540	HepG2	liver:	n/a	n/a
5	BACH1	chr9:1005054-1005459	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr9:1018136-1018550	HepG2	liver:	n/a	chr9:1018361-1018370 chr9:1018359-1018372 chr9:1018362-1018371 chr9:1018361-1018370 chr9:1018360-1018369 chr9:1018355-1018376
7	BHLHE40	chr9:1009121-1009447	K562	blood:	n/a	chr9:1009235-1009251
8	BHLHE40	chr9:1005037-1005437	GM12878	blood:	n/a	n/a
9	BHLHE40	chr9:1018181-1018542	GM12878	blood:	n/a	chr9:1018361-1018370 chr9:1018359-1018372 chr9:1018362-1018371 chr9:1018361-1018370 chr9:1018360-1018369 chr9:1018355-1018376
10	BHLHE40	chr9:1029343-1029345	A549	lung:	n/a	n/a
11	BHLHE40	chr9:1018168-1018552	K562	blood:	n/a	chr9:1018361-1018370 chr9:1018359-1018372 chr9:1018362-1018371 chr9:1018361-1018370 chr9:1018360-1018369 chr9:1018355-1018376
12	BHLHE40	chr9:1009153-1009539	GM12878	blood:	n/a	chr9:1009235-1009251
13	BHLHE40	chr9:1018311-1018500	A549	lung:	n/a	chr9:1018361-1018370 chr9:1018359-1018372 chr9:1018362-1018371 chr9:1018361-1018370 chr9:1018360-1018369 chr9:1018355-1018376
14	BHLHE40	chr9:1009111-1009469	HepG2	liver:	n/a	chr9:1009235-1009251
15	BRCA1	chr9:1009140-1009395	Hela-S3	cervix:	n/a	n/a
16	BRCA1	chr9:1009179-1009384	HepG2	liver:	n/a	n/a
17	CEBPB	chr9:1030669-1030723	A549	lung:	n/a	n/a
18	CEBPB	chr9:1005027-1005521	MCF-7	breast:	n/a	n/a
19	CEBPB	chr9:1009159-1009464	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr9:1008255-1008623	IMR90	lung:	n/a	n/a
21	CEBPB	chr9:1006646-1006667	H1-hESC	embryonic stem cell:	n/a	n/a
22	CEBPB	chr9:1008314-1008607	A549	lung:	n/a	n/a
23	CEBPB	chr9:1005104-1005356	HepG2	liver:	n/a	n/a
24	CEBPB	chr9:1018102-1018487	MCF-7	breast:	n/a	n/a
25	CEBPB	chr9:1007173-1007672	MCF-7	breast:	n/a	chr9:1007420-1007431
26	CEBPB	chr9:1007119-1007701	MCF-7	breast:	n/a	chr9:1007420-1007431
27	CEBPB	chr9:1007275-1007607	A549	lung:	n/a	chr9:1007420-1007431
28	CEBPB	chr9:1007275-1007605	HepG2	liver:	n/a	chr9:1007420-1007431
29	CEBPB	chr9:1005051-1005367	A549	lung:	n/a	n/a
30	CEBPB	chr9:1005008-1005372	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr9:1007270-1007577	IMR90	lung:	n/a	chr9:1007420-1007431
32	CHD1	chr9:1009154-1009437	GM12878	blood:	n/a	n/a
33	CHD2	chr9:1009154-1009544	GM12878	blood:	n/a	n/a
34	CHD2	chr9:1009169-1009480	HepG2	liver:	n/a	n/a
35	CREB1	chr9:1009145-1009543	A549	lung:	n/a	n/a
36	CTCF	chr9:1009155-1009433	GM13977	blood:	n/a	chr9:1009272-1009288 chr9:1009273-1009286 chr9:1009271-1009289 chr9:1009276-1009284 chr9:1009266-1009287
37	CTCF	chr9:1005157-1005385	K562	blood:	n/a	n/a
38	CTCF	chr9:1018086-1018394	A549	lung:	n/a	chr9:1018297-1018315 chr9:1018300-1018309 chr9:1018299-1018320
39	CTCF	chr9:1009160-1009310	HAc	cerebellar:	n/a	chr9:1009272-1009288 chr9:1009273-1009286 chr9:1009271-1009289 chr9:1009276-1009284 chr9:1009266-1009287
40	CTCF	chr9:1009220-1009370	HMF	breast:	n/a	chr9:1009272-1009288 chr9:1009273-1009286 chr9:1009271-1009289 chr9:1009276-1009284 chr9:1009266-1009287
41	CTCF	chr9:1018180-1018330	K562	blood:	n/a	chr9:1018297-1018315 chr9:1018300-1018309 chr9:1018299-1018320
42	CTCF	chr9:1005065-1005469	IMR90	lung:	n/a	n/a
43	CTCF	chr9:1018184-1018390	ProgFib	skin:	n/a	chr9:1018297-1018315 chr9:1018300-1018309 chr9:1018299-1018320
44	CTCF	chr9:1009200-1009350	GM06990	blood:	n/a	chr9:1009272-1009288 chr9:1009273-1009286 chr9:1009271-1009289 chr9:1009276-1009284 chr9:1009266-1009287
45	CTCF	chr9:1009200-1009350	AoAF	blood vessel:	n/a	chr9:1009272-1009288 chr9:1009273-1009286 chr9:1009271-1009289 chr9:1009276-1009284 chr9:1009266-1009287
46	CTCF	chr9:1005160-1005310	GM12878	blood:	n/a	n/a
47	CTCF	chr9:1005200-1005350	SK-N-SH_RA	brain:	n/a	n/a
48	CTCF	chr9:1009220-1009370	RPTEC	kidney:	n/a	chr9:1009272-1009288 chr9:1009273-1009286 chr9:1009271-1009289 chr9:1009276-1009284 chr9:1009266-1009287
49	CTCF	chr9:1004950-1005528	MCF-7	breast:	n/a	n/a
50	CTCF	chr9:1018198-1018375	GM12891	blood:	n/a	chr9:1018297-1018315 chr9:1018300-1018309 chr9:1018299-1018320

No.	Distal block	Cell Line	Cell type
1	chr9:893739..894732-chr9:1008819..1009733,5	MCF-7	breast:
2	chr9:893523..894096-chr9:1008794..1009361,2	MCF-7	breast:
3	chr9:1017784..1019327-chr9:1158625..1160475,2	MCF-7	breast:
4	chr9:887794..889918-chr9:1005357..1008295,2	MCF-7	breast:
5	chr9:1009051..1010072-chr9:1017840..1018709,4	MCF-7	breast:
6	chr9:826413..827016-chr9:1004866..1005745,2	MCF-7	breast:
7	chr9:893903..894431-chr9:1004790..1005383,2	K562	blood:
8	chr9:1009051..1010072-chr9:1017840..1018709,4	MCF-7	breast:
9	chr9:1007423..1009287-chr9:1045081..1047981,2	MCF-7	breast:
10	chr9:1017828..1018465-chr9:1337011..1337699,2	MCF-7	breast:
11	chr9:893804..894399-chr9:1008894..1009774,3	K562	blood:
12	chr9:1017910..1018696-chr9:1429132..1429802,2	MCF-7	breast:
13	chr9:385756..386457-chr9:1008777..1009377,2	MCF-7	breast:
14	chr6:89674376..89674876-chr9:1017838..1018522,2	MCF-7	breast:
15	chr9:998424..999235-chr9:1008893..1009451,2	MCF-7	breast:
16	chr9:613814..614512-chr9:1017801..1018342,2	MCF-7	breast:
17	chr9:1027853..1029813-chr9:1036990..1039141,2	MCF-7	breast:
18	chr9:1025025..1027123-chr9:1035278..1038960,3	MCF-7	breast:
19	chr9:892531..895372-chr9:1005273..1008806,3	MCF-7	breast:
20	chr9:763938..764768-chr9:1004823..1005723,3	MCF-7	breast:
21	chr9:890713..892471-chr9:1006171..1008763,2	MCF-7	breast:
22	chr7:31567098..31567732-chr9:1023490..1024312,2	MCF-7	breast:
23	chr9:1017795..1018400-chr9:1429068..1429992,2	MCF-7	breast:
24	chr9:1017972..1018656-chr9:1527877..1528623,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf66-11	chr9:1031219-1031345	NONHSAT129957
2	lnc-C9orf66-11	chr9:1031868-1032520	NONHSAT129957
3	lnc-DMRT3-4	chr9:1011710-1011799	NONHSAT129956
4	lnc-DMRT3-4	chr9:1011085-1011386	NONHSAT129956

Variant related genes	Relation type
ENSG00000228783	TF binding region
RNU6-1073P	TF binding region

Extended variants
information (count: 1230 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:1230 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs551190698	chr9:1003766-1003767	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs144447736	chr9:1003800-1003801	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs539988755	chr9:1003827-1003828	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs147823332	chr9:1003849-1003850	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs548423712	chr9:1003882-1003883	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs568744681	chr9:1003883-1003884	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs537237897	chr9:1003908-1003909	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs10978128	chr9:1003942-1003943	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs141441988	chr9:1003954-1003955	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs10978129	chr9:1003994-1003995	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs185045009	chr9:1003997-1003998	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs572024556	chr9:1004000-1004001	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs571934619	chr9:1004046-1004047	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs116568098	chr9:1004072-1004073	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs143582532	chr9:1004076-1004077	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs575188994	chr9:1004078-1004079	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs574724829	chr9:1004088-1004089	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs187994707	chr9:1004111-1004112	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs10816262	chr9:1004151-1004152	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs530833897	chr9:1004152-1004153	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs576977835	chr9:1004163-1004164	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs545862856	chr9:1004165-1004166	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs559420982	chr9:1004183-1004184	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs528428687	chr9:1004189-1004190	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs548217266	chr9:1004209-1004210	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs562240058	chr9:1004248-1004249	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs147985873	chr9:1004260-1004261	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs550746093	chr9:1004271-1004272	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs558005815	chr9:1004272-1004273	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs57082258	chr9:1004298-1004299	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs182142981	chr9:1004358-1004359	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs187259637	chr9:1004373-1004374	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs191640535	chr9:1004404-1004405	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs565824163	chr9:1004407-1004408	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs1567354	chr9:1004415-1004416	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs554580861	chr9:1004473-1004474	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs532992781	chr9:1004483-1004484	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs574631195	chr9:1004552-1004553	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs537315896	chr9:1004561-1004562	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs183599071	chr9:1004573-1004574	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs376222520	chr9:1004579-1004580	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs1572804	chr9:1004648-1004649	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs150082832	chr9:1004685-1004686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs553466137	chr9:1004730-1004731	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs185808416	chr9:1004801-1004802	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs573047905	chr9:1004860-1004861	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs4742633	chr9:1004881-1004882	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs190223467	chr9:1004896-1004897	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs74410763	chr9:1004905-1004906	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs551210821	chr9:1004919-1004920	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Cancer	21272361	CNVD
Autism	22495311	CNVD
Ependymoma	20639864	CNVD

Chromatin state (count:120 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:996400-1007400	Weak transcription	Muscle Satellite Cultured Cells	--
2	chr9:1000200-1009200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
3	chr9:1000600-1004800	Weak transcription	Primary monocytes fromperipheralblood	blood
4	chr9:1002200-1007000	Weak transcription	HSMM	muscle
5	chr9:1002200-1007600	Weak transcription	HSMMtube	muscle
6	chr9:1002600-1004200	Enhancers	GM12878-XiMat	blood
7	chr9:1002800-1007000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr9:1004200-1004600	Weak transcription	GM12878-XiMat	blood
9	chr9:1004400-1005000	Weak transcription	Adipose Nuclei	Adipose
10	chr9:1004600-1005800	Enhancers	GM12878-XiMat	blood
11	chr9:1004800-1005000	Bivalent Enhancer	Brain Angular Gyrus	brain
12	chr9:1004800-1005200	Enhancers	iPS-15b Cell Line	embryonic stem cell
13	chr9:1004800-1005200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr9:1004800-1005400	Enhancers	Primary monocytes fromperipheralblood	blood
15	chr9:1005000-1005200	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr9:1005000-1005200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr9:1005000-1005200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
18	chr9:1005000-1005200	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
19	chr9:1005000-1005200	Enhancers	Adipose Nuclei	Adipose
20	chr9:1005000-1005200	Flanking Bivalent TSS/Enh	Brain Angular Gyrus	brain
21	chr9:1005000-1005200	Flanking Bivalent TSS/Enh	Brain Inferior Temporal Lobe	brain
22	chr9:1005000-1005200	Bivalent Enhancer	Colon Smooth Muscle	Colon
23	chr9:1005000-1005400	Enhancers	Brain Hippocampus Middle	brain
24	chr9:1005000-1005400	Enhancers	Monocytes-CD14+_RO01746	blood
25	chr9:1005200-1006800	Weak transcription	Adipose Nuclei	Adipose
26	chr9:1005200-1007600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
27	chr9:1005400-1007400	Weak transcription	Primary monocytes fromperipheralblood	blood
28	chr9:1005400-1007600	Weak transcription	Monocytes-CD14+_RO01746	blood
29	chr9:1005800-1006200	Weak transcription	GM12878-XiMat	blood
30	chr9:1006200-1006400	Enhancers	GM12878-XiMat	blood
31	chr9:1006400-1009200	Weak transcription	GM12878-XiMat	blood
32	chr9:1006800-1007800	Enhancers	Adipose Nuclei	Adipose
33	chr9:1007000-1009600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr9:1007000-1009600	Enhancers	HSMM	muscle
35	chr9:1007200-1008400	Enhancers	Fetal Muscle Leg	muscle
36	chr9:1007200-1009800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr9:1007400-1009600	Enhancers	Muscle Satellite Cultured Cells	--
38	chr9:1007400-1011000	Enhancers	Primary monocytes fromperipheralblood	blood
39	chr9:1007600-1007800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr9:1007600-1008800	Enhancers	HSMMtube	muscle
41	chr9:1007600-1011000	Enhancers	Monocytes-CD14+_RO01746	blood
42	chr9:1007800-1008600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr9:1007800-1009200	Weak transcription	Adipose Nuclei	Adipose
44	chr9:1008200-1009600	Enhancers	Osteobl	bone
45	chr9:1008400-1009200	Weak transcription	Fetal Muscle Leg	muscle
46	chr9:1008600-1009000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr9:1008800-1009400	Weak transcription	HSMMtube	muscle
48	chr9:1009000-1009200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr9:1009000-1010000	Enhancers	HMEC	breast
50	chr9:1009200-1009400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links